Sharechat Logo

Forum Archive Index - September 2001

Please note usage of the Forum is subject to the Terms & Conditions.

 
Messages by Date [ Next by Date Previous by Date ]
Messages by Thread [ Next by Thread Previous by Thread ]
Post to the Forum [ New message Reply to this message ]
Printable version
 

Re: Re: [sharechat] Genesis ( NZSE.GEN ) or Peptech ( AX. PTD )


From: "ryanrite" <ryanrite@xtra.co.nz>
Date: Sun, 30 Sep 2001 10:33:48 +1200


Gerry
Have you heard anythink about CLI
have they found some support yet or are they still going to fall
I did not think they had exposure to share market fall or America
If not why are they falling
Maybe you could help out if you know why
Athol
----- Original Message -----
From: G Stolwyk
Sent: Saturday, September 29, 2001 11:47 AM
Subject: Re: Re: [sharechat] Genesis ( NZSE.GEN ) or Peptech ( AX. PTD )

Readers, before proceeding, please read the Disclaimer in my previous post! 

 
Thank you, Colin!
 
I always appreciate a comment from a pharmacist!
 
There is a large market for anti-TNF pharmaceuticals now.
Below are comments from " Decision Resources, Inc." which reviews the commercial potential of novel agents in this field:
 
 The TNF-Alpha Inhibitors in therapeutic products: " Etanercept "( Immmunex/Wyeth-Ayerst's Enbrel ), " Infliximab " ( Centocor/ Johnson@ Johnson's Remicade ) being used in the rheumatoid arthritis ( RA ) and inflammatory bowel disease( IBD).
 
They predict that by 2010 approx. 37% of the anti-TNF market place will be attributed to sales in novel indications.
 
Psoriasis and Psoriatic Arthritis trials are now in late-stage clinical development  and the TNF inhibitor will be the principal driver of growth in this market according to forecasts.
 
Congestive Heart Failure ( CHF) This seems to be associated with high levels of TNF bio activity. This requires further study.
 
Sepsis: A modest but definite beneficial effect by application of a refined anti- TNF product " Afelimomab " ( Knoll/Abbott's Segard ) in an improved clinical trial design, have been noted.  
 
Yes, I have followed the TNF- Alpha Inhibitor market closely; it is showing great promise and profits are rising exponentially: It is a massive market! 
 
This post and the previous one were mainly written for this site:
 
 
This is the prime Australian Message Board on PTD.
 
 I promised to do a summary of the status of PTD: See post 3241on that site.
 
( See also posts 340 and 1069 from the MMD Message Board).
 
There are some principal contributors there and they are nice people to work with: these traders are a team and act accordingly.
 
Gerry

References

 
Messages by Date [ Next by Date: [sharechat] share options Philip Robinson
Previous by Date: [sharechat] executives share options in NZ Fern Leaf ]
Messages by Thread [ Next by Thread: Re: Re: [sharechat] Genesis ( NZSE.GEN ) or Peptech ( AX. PTD ) G Stolwyk
Previous by Thread: Re: Re: [sharechat] Genesis ( NZSE.GEN ) or Peptech ( AX. PTD ) G Stolwyk ]
Post to the Forum [ New message Reply to this message ]